Reaction
Nasal Cavity Cancer reporting signals
As of the last recalculation, Nasal Cavity Cancer appears in 911 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is RANITIDINE HYDROCHLORIDE (PRR 87.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ranitidine Hydrochloride | 170 | 87.6 | 87.9 |
| Ranitidine | 222 | 33.4 | 33.4 |
| Mycophenilic Acid | 14 | 15.7 | 15.7 |